Establishing In Situ Closed Circuit Perfusion of Lower Abdominal Organs and Hind Limbs in Mice
August 13th, 2020
6K views
A protocol is described for in situ perfusion of the mouse lower body, including the bladder, the prostate, sex organs, bone, muscle and foot skin.
Overview
This protocol describes an in situ perfusion technique for the mouse lower body, targeting organs such as the bladder, prostate, sex organs, bone, muscle, and foot skin. It enables researchers to study drug delivery and immune interactions within these organs without traditional ex-vivo limitations.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Pharmacology
Background
- Traditional ex-vivo methods have limitations in perfusing certain organs.
- This technique avoids main clearance organs, allowing for targeted studies.
- It is particularly useful for understanding drug delivery mechanisms.
- Immune interactions can be assessed within the perfused organs.
Purpose of Study
- To develop a method for in situ perfusion of the mouse lower body.
- To facilitate research on drug delivery to specific organs.
- To investigate immune responses in the perfused tissues.
Methods Used
- Preparation of a circulating water bath and water-jacketed components at 37 degrees Celsius.
- Use of a bubble trap within a moist chamber as the perfusate reservoir.
- Catheterization of the mouse in a supine position.
- Confirmation of anesthesia through lack of response to pedal reflex.
Main Results
- Successful perfusion of the bladder, prostate, and other lower body organs.
- Enhanced understanding of drug delivery dynamics.
- Insights into immune interactions within the perfused organs.
- Demonstration of the feasibility of this technique for future studies.
Conclusions
- The in situ perfusion technique is effective for studying lower body organs in mice.
- This method opens new avenues for research in drug delivery and immunology.
- Future applications may include various therapeutic and experimental contexts.
Frequently Asked Questions
What is in situ perfusion?
In situ perfusion is a technique that allows for the delivery of fluids directly into organs while they remain in the living organism.
Why is this method preferred over traditional ex-vivo methods?
This method avoids the limitations of traditional ex-vivo techniques, allowing for more accurate studies of drug delivery and immune interactions.
What organs can be perfused using this protocol?
The protocol allows for the perfusion of the bladder, prostate, sex organs, bone, muscle, and foot skin in mice.
How is anesthesia confirmed before the procedure?
Anesthesia is confirmed by checking for a lack of response to pedal reflex in the mouse.
What temperature should the water bath be set to?
The circulating water bath should be set to 37 degrees Celsius before starting the procedure.
What is the purpose of using a bubble trap?
A bubble trap is used to limit the perfusate volume and ensure a smooth flow during the perfusion process.
Executive Industry Relevance
This in situ perfusion model enables direct study of drug delivery and immune interactions in traditionally inaccessible mouse organs such as bladder, prostate, bone marrow, and skin, bypassing hepatic and renal clearance. It supports mechanistic de-risking by providing a physiologically relevant system to evaluate compound biodistribution and target engagement in lower abdominal tissues. The approach enhances predictive confidence in preclinical screening by allowing real-time assessment of therapeutic uptake and tissue-specific responses under controlled perfusion conditions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in organs not accessible via traditional ex-vivo perfusion, supporting functional target validation in bladder, prostate, and reproductive tissues.
- Operational Value: Provides a reproducible system to assess drug accumulation pathways and immune cell interactions within perfused tissues.
- Predictive Value: Facilitates mechanistic de-risking by allowing direct observation of compound distribution and tissue response in a closed-circuit system.
Screening & Assay Development
- Scientific Value: Generates quantitative fluorescence and histological readouts (e.g., Hoechst and lectin staining) to assess microvascular perfusion and cellular uptake in perfused organs.
- Operational Value: Standardizes perfusion parameters (0.6 mL/min flow rate, 37°C, up to 2 hours) for consistent compound screening across laboratories.
- Predictive Value: Enables evaluation of drug delivery mechanisms in physiologically relevant microenvironments, improving assay translatability to in vivo conditions.
Translational & Preclinical Research
- Scientific Value: Supports investigation of circulating tumor cell migration and immune-organ interactions in a disease-relevant system comprising bone marrow, bladder, prostate, and skin.
- Operational Value: Allows longitudinal perfusion studies to model chronic exposure scenarios and assess tissue-specific toxicity or efficacy signals.
- Predictive Value: Enhances preclinical decision-making by providing early insights into organ-specific drug retention and microenvironmental influences on therapeutic efficacy.
Pipeline & Workflow Integration
The method integrates into the discovery continuum by enabling early-stage evaluation of drug delivery to lower abdominal organs, informing lead optimization and preclinical prioritization through direct tissue exposure data.
- Discovery Biology: Supports hypothesis testing on organ-specific drug uptake and immune modulation in perfused tissues such as testes, bone marrow, and foot skin.
- Screening: Delivers standardized, quantitative perfusion outputs (fluorescent lectin/Hoechst staining, H&E histology) to compare compound performance across conditions.
- Analytics: Provides measurable endpoints including vascular perfusion efficiency, nuclear staining intensity, and histological tissue integrity for comparative analysis.
- Translational Research: Connects discovery findings to preclinical validation by modeling human-relevant organ interactions in a murine lower-body system.
- Enterprise Reuse: Establishes a reusable perfusion platform for iterative screening of therapeutics, nanoparticles, or immune modulators across multiple organ systems.
Operational & Enterprise Impact
- Scientific Value: Increases target validation confidence by enabling direct observation of drug-tissue interactions in physiologically preserved microenvironments.
- Operational Value: Ensures reproducibility through standardized cannulation, flow rate control, and temperature maintenance across experimental runs.
- Strategic Value: Reduces late-stage attrition by improving early prediction of organ-specific drug distribution and microenvironmental effects.
- Portfolio Impact: Informs risk-adjusted advancement decisions by delivering early data on drug accumulation in traditionally hard-to-perfuse organs.
Implementation Considerations
- Requires microsurgical expertise in vessel catheterization and ligation under dissection microscopy.
- Dependent on perfusion infrastructure including peristaltic pumps, water-jacketed chambers, and bubble traps for reservoir management.
- Necessitates cross-team standardization of perfusion parameters (flow rate, temperature, duration) to ensure data comparability.
- Involves adaptation considerations when extending the model to disease models or genetically modified mice.
- Limited by the 2-hour perfusion window, which constrains long-term exposure studies but supports acute mechanistic investigations.
Biopharma FAQs
Why is bypassing kidney and liver perfusion important for drug delivery studies?
Bypassing the main clearance organs (kidney, liver, spleen) prevents rapid drug metabolism and excretion, allowing sustained exposure to test compounds in target tissues such as bladder, prostate, and bone marrow. This enables clearer assessment of intrinsic drug uptake pathways and tissue-specific accumulation without confounding systemic clearance effects.
How does isolating the lower abdominal circuit improve mechanistic de-risking in preclinical studies?
Isolating the circuit allows researchers to study drug delivery and immune interactions in a controlled microenvironment, free from interference by systemic clearance or metabolic organs. This supports mechanistic de-risking by enabling direct observation of compound behavior in perfused tissues like skin, testes, and bone marrow under physiological flow conditions.
What quantitative measurements validate successful perfusion in this model?
Successful perfusion is validated by fluorescent lectin (DyLight-649) and Hoechst 33342 staining, which demonstrate efficient microvascular filling and nuclear labeling in tissues such as muscle, bone marrow, testes, bladder, prostate, and foot skin. Histological confirmation via H&E staining further shows tissue integrity and absence of injury after perfusion.
Why are replication and standardization critical for cross-functional use of this perfusion system?
Replication ensures consistent perfusion outcomes across experiments, which is essential for reliable compound comparison and data sharing between discovery, pharmacology, and toxicology teams. Standardization of flow rate (0.6 mL/min), temperature (37°C), and circuit setup minimizes variability and supports assay robustness in multi-user environments.
What analytical capabilities are needed to assess perfusion efficiency and drug uptake in this system?
Required capabilities include fluorescence microscopy for lectin and Hoechst staining visualization, histological processing for H&E evaluation, and quantitative image analysis to measure vascular perfusion intensity and cellular drug accumulation. These tools enable objective assessment of perfusion success and compound distribution in perfused organs.
